TESARO Announces Data Presentations at ESMO 2018 Congress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/20/2026
- Wall St gains as chips recover; megacap earnings in focus
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
- Why Moonshot AI's Kimi K3 is actually bullish for memory stocks
- AMC Entertainment soars on record quarterly results
- Cantor Fitzgerald Starts Trulieve Cannabis (TRLV) at Overweight, 'Purpose-Built for a New Cannabis Regulatory Framework'
- Wall St gains as chips recover; megacap earnings in focus
- Oil steadies as hopes of renewed US-Iran negotiations offset Houthi threat
- IREN raises 2026 revenue target to $4bn after $2.8bn in contracts
- Selloff of U.S. memory stocks creates a compelling entry point: analyst
Tesaro (TSRO) PT Raised to $68 at Cantor Fitzgerald Following Strong SOLO1 Data
October 22, 2018 8:51 AM EDTCantor Fitzgerald analyst Alethia Young raised the price target on Tesaro (NASDAQ: TSRO) to $68.00 (from $57.00) while maintaining an Overweight rating. Today at the European oncology meeting, AstraZeneca presented the SOLO1 study using olaparib (a PARP inhibitor) as a first-line treatment for BRCA ovarian... More
